References
Filters: Author is Zeuzem, Stefan [Clear All Filters]
ENDURANCE-1: efficacy and safety of 8- versus 12-week treatment with ABT-493/ABT-530 in patients with chronic HCV genotype 1 infection [abstract 253]. In: The Liver Meeting 2016. The Liver Meeting 2016. Boston, MA; 2016.
.